Corifact
Jeneng umum: Factor XIII
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Corifact
Corifact digunakake kanggo nyegah episode getihen ing wong sing duwe kelainan getihen turun temurun sing disebabake kekurangan Faktor XIII.
Faktor XIII (telulas) iku kedadeyan alamiah. protein ing getih sing mbantu getih kanggo beku. Kekurangan faktor pembekuan bisa nyebabake pendarahan sing ora bisa dikontrol, amarga getih ora bisa beku kanthi bener. Obat iki dianggo kanthi ngunggahake tingkat faktor XIII iki ing getih kanggo mbantu pembekuan.
Corifact ora bakal nambani episode getihen sing wis diwiwiti.
Corifact uga bisa digunakake. kanggo tujuan sing ora kadhaptar ing pandhuan pengobatan iki.
Corifact efek sisih
Entuk bantuan medis darurat yen sampeyan duwe tandha reaksi alergi Corifact: gatal-gatal; ambegan angel; kroso entheng; bengkak ing rai, lambe, ilat, utawa tenggorokan.
Nelpon dhokter sampeyan yen sampeyan duwe:
Efek samping Corifact sing umum bisa kalebu:
Iki dudu daftar lengkap sisih efek lan liya-liyane bisa kedadeyan. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Corifact
Sampeyan ora kudu nggunakake Corifact yen sampeyan alergi marang faktor XIII utawa obat apa wae sing digawe karo plasma manungsa.
Kanggo mesthekake Corifact aman kanggo sampeyan, hubungi dhokter yen sampeyan duwe:
Ora dingerteni manawa Corifact bakal ngrusak bayi sing durung lair. Marang dhokter sampeyan yen sampeyan lagi ngandhut utawa arep ngandhut nalika nggunakake obat iki.
Ora dingerteni manawa faktor XIII mlebu ing ASI utawa bisa ngrusak bayi sing lagi nyusoni. Marang dhokter yen sampeyan lagi nyusoni bayi.
Corifact digawe saka plasma manungsa (bagean getih) sing bisa ngemot virus lan agen infèksi liyane. Plasma sing disumbang dites lan diobati kanggo nyuda risiko ngemot agen infèksius, nanging isih ana kemungkinan cilik bisa nularake penyakit. Rembugan karo dhokter sampeyan babagan risiko lan keuntungan nggunakake obat iki.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Corifact
Corifact disuntikake menyang vena liwat IV. Sampeyan bisa uga ditampilake carane nggunakake IV ing ngarep. Aja nyuntikake obat iki dhewe yen sampeyan ora ngerti carane menehi injeksi lan mbuwang jarum bekas, tabung IV, lan barang liyane sing digunakake kanggo nyuntikake obat kasebut.
Corifact biasane diwenehake saben sapisan. 4 minggu. Tindakake instruksi dosis saka dokter kanthi ati-ati.
Corifact minangka obat bubuk sing kudu dicampur karo cairan (pengencer) sadurunge digunakake. Yen sampeyan nggunakake injeksi ing omah, priksa manawa sampeyan ngerti carane nyampur lan nyimpen obat kanthi bener.
Ayo campuran tekan suhu kamar sadurunge menehi injeksi. Aja panas obat sadurunge digunakake.
Corifact kudu katon bening utawa rada kuning ing werna. Aja nggunakake obat kasebut yen wis ganti warna utawa ana partikel. Nelpon dhokter kanggo resep anyar.
Aja nyampur Corifact karo obat suntik liyane ing baris IV sing padha.
Saben vial (botol) obat iki kanggo siji panggunaan. mung. Buang sawise siji nggunakake, sanajan isih ana obat sing isih ana sawise nyuntikake dosis sampeyan.
Gunakake jarum sing bisa digunakake mung sapisan. Tindakake hukum negara utawa lokal babagan mbuwang jarum lan jarum suntik bekas. Gunakake wadhah pembuangan "sharps" sing tahan tusukan (takon apoteker sampeyan entuk lan kepiye cara mbuwang). Simpen wadhah iki saka jangkauan bocah lan kewan.
Nalika nggunakake obat iki, sampeyan bisa uga kudu kerep tes getih.
Simpen Corifact sing ora dicampur ing kulkas, aja beku. Simpen obat ing wadhah asline.
Botol sing durung dibukak uga bisa disimpen ing suhu kamar nganti 6 sasi, adoh saka kelembapan, panas, lan cahya. Aja didinginkan vial sing durung dibukak sing wis disimpen ing suhu kamar.
Sawise dicampur karo diluent, simpen ing suhu kamar lan gunakake sajrone 4 jam. . Aja disimpen ing kulkas utawa beku.
Buang Corifact sing ora digunakake sawise tanggal kadaluwarsa ing label wis liwati.
Pènget
Sampeyan ora kudu nggunakake Corifact yen sampeyan alergi marang obat apa wae sing digawe karo plasma manungsa.
Sadurunge nggunakake Corifact, takon dhokter yen sampeyan duwe penyakit ati.
Sampeyan bisa uga ditampilake carane nggunakake IV ing ngarep. Aja nyuntikake Corifact dhewe yen sampeyan ora ngerti carane menehi injeksi lan mbuwang jarum bekas, tabung IV, lan barang liyane sing digunakake kanggo nyuntikake obat kasebut.
Hubungi dhokter sampeyan langsung yen sampeyan ngalami episode getihen anyar utawa saya tambah parah, mati rasa utawa kelemahane dadakan, nyeri dada, watuk getih, masalah penglihatan utawa wicara, utawa nyeri, bengkak, panas, utawa abang ing sikil siji utawa loro.
Apa obatan liyane bakal mengaruhi Corifact
Obat liyane bisa berinteraksi karo faktor XIII, kalebu obat resep lan obat bebas, vitamin, lan produk herbal. Marang saben panyedhiya layanan kesehatan babagan kabeh obat sing sampeyan gunakake saiki lan obat apa wae sing sampeyan wiwiti utawa mandheg nggunakake.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions